Last update 01 Nov 2024
Xiamen Encheng Pharmaceutical Co., Ltd
Private Company|
2006|
Fujian Sheng, China
Last update 01 Nov 2024
Overview
Basic Info
Introduction The pharmaceutical company Xiamen Earnest Pharma Co., Ltd. was established on December 22, 2006, as a wholly-owned subsidiary of the Earnest Group. The parent group, Earnest, constitutes a diversified corporate entity that integrates the complete medical supply chain, precision medicine, cultural media, and investment activities. |
Tags
Digestive System Disorders
Neoplasms
Mouth and Tooth Diseases
Small molecule drug
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
在健康成年受试者中进行的单中心、随机、开放、两周期、两序列、交叉、单次给药试验设计，评价空腹/餐后状态下的生物等效性研究。
[Translation] A single-center, randomized, open-label, two-period, two-sequence, crossover, single-dose study was conducted in healthy adult subjects to evaluate the bioequivalence under fasting/fed conditions.
本研究为在健康成年受试者中进行的单中心、随机、开放、双交叉、两周期、单次给药试验设计，进行空腹或餐后状态下的药代动力学研究。
[Translation] This study was a single-center, randomized, open-label, double-crossover, two-period, single-dose trial designed in healthy adult subjects to investigate the pharmacokinetic properties of the drug in the fasting or fed state.
本研究为在健康成年受试者中进行的单中心、随机、开放、双交叉、两周期、单次给药试验设计，进行空腹或餐后状态下的药代动力学研究。
[Translation] This study was a single-center, randomized, open-label, double-crossover, two-period, single-dose trial designed in healthy adult subjects to investigate the pharmacokinetic properties of the drug in the fasting or fed state.
100 Clinical Results associated with Xiamen Encheng Pharmaceutical Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Xiamen Encheng Pharmaceutical Co., Ltd
Login to view more data
100 Translational Medicine associated with Xiamen Encheng Pharmaceutical Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
1
NDA/BLA
Approved
2
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free